Harbour BioMed and Moderna Ink Licensing Deal for Oncology Immunotherapies
Harbour BioMed (HKG: 2142), a biotech company with operations in the United States, the Netherlands,...
Harbour BioMed (HKG: 2142), a biotech company with operations in the United States, the Netherlands,...
Autoimmune disease drug developer Zenas BioPharma, which is based in the US and China, has...
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline...
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at...
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda...
A strategic partnership between China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) and Bayer Consumer...
US-based Medtronic Inc. (NYSE: MDT) has announced a partnership with Shanghai JiaHui International Hospital, unveiled...
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes,...
Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th...
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company based in Hong Kong, has announced...
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between US-based...
The 5th China International Import Expo (CIIE) saw US-based Pfizer’s China unit announce a partnership...
China-based Adicon Holdings Limited has announced a strategic partnership with US-based Illumina (NASDAQ: ILMN) at...
US-based Pfizer (NYSE: PFE) has initiated a strategic partnership with the China Cardiovascular Association (CCA),...
US-based Pfizer (NYSE: PFE) has initiated a strategic partnership with the China Cardiovascular Association (CCA),...
Mainline Biosciences, a polypeptide drug developer based in Zhongshan, has reportedly raised close to RMB...
China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused...